Topic
Oxford-AstraZeneca
UK govt approves Covaxin for international travellers
The move follows the World Health Organisation’s (WHO) Emergency Use Listing for Covaxin The UK government has said that India’s…
Govt revises interval for Covishield vaccine by up to eight weeks
Earlier, the dosage was being provided at an interval of four to six weeks The government revised the interval between…
India studies post-vaccination adverse events of Covishield
India has reported 234 adverse events following immunisation (AEFIs), including 71 deaths, for both the vaccines till now Amid concerns…
Bangladesh receives first COVID-19 vaccine consignment from India
A special Air India flight carrying the Oxford-AstraZeneca COVID-19 vaccine co-manufactured by Serum Institute of India reached the Hazrat Shahjalal…
Ready to roll out COVID-19 vaccine in India: Serum
The company has already stockpiled around 50 million dosages of the vaccine Serum Institute of India (SII) on Sunday said…
India approves Oxford-AstraZeneca covid vaccine
The government and the SII are yet to sign an agreement on the purchase of the vaccine The Central Drugs…
Serum Institute seeks emergency use authorisation for Covishield in India
The phase-three clinical trial of the Oxford COVID-19 vaccine, Covishield, is being conducted by the Pune-based Serum Institute of India…